Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management (Q37849392)

24 August 2017

Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management (English)

1 reference

pelvic inflammatory diseases

24 August 2017

0 references

0 references

diagnosis

0 references

author name string

Richard L Sweet

series ordinal

1

1 reference

24 August 2017

2 February 2012

1 reference

Current infectious disease reports

24 August 2017

1 reference

Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001.

24 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Epidemiology, pathogenesis and treatment of pelvic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Lower quality of life among women with chronic pelvic pain after pelvic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Antibiotic therapy for acute pelvic inflammatory disease: the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Comparison of acute and subclinical pelvic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Serum CRP in the diagnosis and treatment of pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Serum CA-125 in the diagnosis of acute pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Etiology of cervical inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Laboratory evaluation of acute upper genital tract infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Polymicrobial etiology of acute pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Etiology and outcome of acute pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Observations concerning the microbial etiology of acute salpingitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Role of bacterial vaginosis-associated microorganisms in endometritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Bacterial vaginosis and anaerobic bacteria are associated with endometritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Association between Mycoplasma genitalium and acute endometritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Bacterial vaginosis and risk of pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Plasma cell endometritis in women with symptomatic bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Bacterial vaginosis as a risk factor for upper genital tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Role of bacterial vaginosis in pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Detection of novel organisms associated with salpingitis, by use of 16S rDNA polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Significant reduction in inflammatory response in the macaque model of chlamydial pelvic inflammatory disease with azithromycin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Acute suppurative salpingitis with concomitant intrauterine pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Concerns regarding the Centers for Disease Control's published guidelines for pelvic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Influence of human immunodeficiency virus infection on pelvic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Effects of human immunodeficiency virus 1 infection on microbial origins of pelvic inflammatory disease and on efficacy of ambulatory oral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Serum CA 125 in acute pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0243-Y

Transvaginal ultrasonographic study of the fallopian tube

21 January 2018

1 reference

12 December 2020

Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results

1 reference

12 December 2020

Microbiological and histopathological findings in acute pelvic inflammatory disease

1 reference

12 December 2020

Pelvic inflammatory disease during pregnancy.

1 reference

12 December 2020

A practical approach to the diagnosis of pelvic inflammatory disease

1 reference

12 December 2020

Pelvic inflammatory disease in human immunodeficiency virus-infected women

1 reference

12 December 2020

Surgical considerations in the diagnosis and treatment of pelvic inflammatory disease

1 reference

12 December 2020

Clinical utility of CA125 levels in predicting laparoscopically confirmed salpingitis in patients with clinically diagnosed pelvic inflammatory disease

1 reference

12 December 2020

Sexually transmitted diseases treatment guidelines, 2010.

1 reference

12 December 2020

Criteria for diagnosis and grading of salpingitis

1 reference

12 December 2020

Sexually transmitted diseases. Pelvic inflammatory disease and infertility in women

1 reference

12 December 2020

Effect of acute pelvic inflammatory disease on fertility

1 reference

12 December 2020

Diagnosis and treatment of pelvic inflammatory disease.

1 reference

12 December 2020

Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial

1 reference

12 December 2020

Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample?

1 reference

12 December 2020

Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy

1 reference

12 December 2020

European guideline for the management of pelvic inflammatory disease

1 reference

12 December 2020

Anatomic sites of upper genital tract infection

1 reference

12 December 2020

Influence of an intrauterine device on the course of an acute salpingitis

1 reference

12 December 2020

Cost-effectiveness of alternative outpatient pelvic inflammatory disease treatment strategies.

1 reference

12 December 2020

Serum CA 125 levels in patients with a provisional diagnosis of pelvic inflammatory disease. Clinical and theoretical implications

1 reference

12 December 2020

Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis

1 reference

12 December 2020

10.1007/S11908-012-0243-Y

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

22298157